Background. Glioblastoma or glioma is the most common malignant brain tumor. Patients have a prognosis of approximately 15 months, despite the current aggressive treatment. Neurokinin-1 receptor (NK-1R) occurs naturally in human glioma, and it is necessary for the tumor development. Objective. The purpose of the study was to increase the...
-
May 11, 2022 (v1)PublicationUploaded on: March 25, 2023
-
November 28, 2023 (v1)Publication
To develop a new therapeutic strategy against thyroid cancer (TC), the expression of both substance P (SP) and neurokinin-1 receptor (NK-1R) must be demonstrated in TC cells. This study aims to examine by immunohistochemistry the localization of SP and the NK-1R in human TC samples (papillary, follicular, medullary, anaplastic) in metastasis...
Uploaded on: November 30, 2023